Home » The Evolving Role of Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Key Findings and Future Directions
The Evolving Role of Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Key Findings and Future Directions
by Kevin Pang, PharmD, Sukeina Nasser, PharmD, CPh, PACS, Rachel Mintz, PharmD, Adina Kagan, PharmD Candidate, Valassia Antigone "Noni" Theocharides, PharmD Candidate & Jerry Ngo, PharmD | Oct 24, 2024 | Articles |
